2012
DOI: 10.1002/jsfa.5615
|View full text |Cite
|
Sign up to set email alerts
|

Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects

Abstract: The aqueous HSE investigated in this study enhanced the systemic AOP and reduced the oxidative stress in humans. Furthermore, the increased urinary hippuric acid excretion after HSE consumption indicates a high biotransformation of the ingested HSE polyphenols, most likely caused by the colonic microbiota.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
1
2

Year Published

2012
2012
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 52 publications
(27 citation statements)
references
References 52 publications
1
23
1
2
Order By: Relevance
“…In a human intervention study, a systemic antioxidant potential was evaluated in eight healthy volunteers 24 h after the ingestion of 10 g of an aqueous HS extract. A significant increase in plasma and urine antioxidant potential and a reduction in oxidative stress was observed, in agreement with animal studies [49]. Furthermore, the main hibiscus anthocyanins and one glucuronide conjugate were detected in the urine of volunteers.…”
Section: Pharmacokinetics and Toxicologysupporting
confidence: 88%
“…In a human intervention study, a systemic antioxidant potential was evaluated in eight healthy volunteers 24 h after the ingestion of 10 g of an aqueous HS extract. A significant increase in plasma and urine antioxidant potential and a reduction in oxidative stress was observed, in agreement with animal studies [49]. Furthermore, the main hibiscus anthocyanins and one glucuronide conjugate were detected in the urine of volunteers.…”
Section: Pharmacokinetics and Toxicologysupporting
confidence: 88%
“…Despite evidence of a correlation between the intake of foods with a high antioxidant content [e.g. walnuts , extract of Hibiscus sabdariffa and green tea ] and plasma and urinary FRAP having been demonstrated, we were not able to demonstrate using robust statistical analysis any differences between trial arms. This was most likely a result of the small sample size, and a ‘fade’ in compliance to the advice, as reflected in the smaller difference in the MD score between groups at 24 weeks compared to 12 weeks.…”
Section: Discussioncontrasting
confidence: 65%
“…Ferric reducing activity power (FRAP) was evaluated according to the previous report in [16] using FeSO 4 ·7H 2 O as the standard. The fresh FRAP reagent was prepared before using, which contains 25 mL acetate buffer (300 mmol/L, pH 3.6), 2.5 mL TPTZ solutions (10 mmol/L in 40 mmol/L HCl), and 2.5 mL of FeCl 3 · 6H 2 O solution (20 mmol/L).…”
Section: Methodsmentioning
confidence: 99%